GARDASIL 9 CPT Vaccine Code: 90651

Vaccine & Product Overview

HCPCS Descriptor Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use

Manufacturer Merck Sharp & Dohme Corp

Route of Administration Intramuscular

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Suspension

About GARDASIL 9

Gardasil 9 is a medication aligned to the HCPCS CPT Drug Code: 90651 for billing, pricing, and reimbursement purposes in the United States. It is a Vaccine drug administered via the intramuscular route and manufactured by Merck Sharp & Dohme Corp.

Manufacturers, reach out to us to add more information.

NDC Code Information

3 NDC packages are crosswalked to 90651. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	GARDASIL 9
	GARDASIL 9
	GARDASIL 9

Login to view 3 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

GARDASIL 9 Pricing & Reimbursement

90651 Private Payer Reimbursement

$358.47 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

GARDASIL 9 Vaccine Administration Codes

CPT Code	Description
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472	Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

GARDASIL 9 Medically Unlikely Edits (MUE)

The most billing units of 90651 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 dose.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

GARDASIL 9 Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Cervical, vulvar, vaginal, anal, oropharyngeal & other head/neck cancers (HPV types 16/18/31/33/45/52/58) Genital warts (condyloma acuminata; HPV 6/11) Precancerous/dysplastic lesions: CIN, VIN, VaIN, AIN (HPV 6/11/16/18/31/33/45/52/58)

Drug Class

Actively Acquired Immunity [PE]Inactivated Human Papillomavirus Vaccine [EPC]Papillomavirus Vaccines [CS]VaccinesInactivated [CS]

Frequently Asked Questions

Is there an available Gardasil 9 billing and coding guide?

Billing and coding information for GARDASIL 9 can be found through Merck. Visit Here →

Are there any available Gardasil 9 patient assistance programs?

GARDASIL 9 patient assistance information can be found through Merck. Visit Here →

Where can I find Gardasil 9 prescribing information?

GARDASIL 9 prescribing information can be found at the link below: Visit Here →

Where can I find Gardasil 9 side effect information?

Information regarding GARDASIL 9's side effects can be found at MedlinePlus Visit Here →

Does billing GARDASIL 9 require JZ/JW wastage modifiers?

CMS does not include GARDASIL 9 (90651) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90651. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.